Rhythm Biosciences Limited Price Chart
Rhythm Biosciences Limited RHY.XA Financial and Trading Overview
| Rhythm Biosciences Limited stock price | 0.08 AUD |
| Previous Close | 0.49 AUD |
| Open | 0.5 AUD |
| Bid | 0.47 AUD x N/A |
| Ask | 0.49 AUD x N/A |
| Day's Range | 0.49 - 0.5 AUD |
| 52 Week Range | 0.31 - 1.62 AUD |
| Volume | 67.15K AUD |
| Avg. Volume | 67.05K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.781226 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.043 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RHY.XA Valuation Measures
| Enterprise Value | 97.65M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 12.250001 |
| Enterprise Value/Revenue | 35.887 |
| Enterprise Value/EBITDA | -11.844 |
Trading Information
Rhythm Biosciences Limited Stock Price History
| Beta (5Y Monthly) | 2.781226 |
| 52-Week Change | -53.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.62 AUD |
| 52 Week Low | 0.31 AUD |
| 50-Day Moving Average | 0.46 AUD |
| 200-Day Moving Average | 0.91 AUD |
RHY.XA Share Statistics
| Avg. Volume (3 month) | 67.05K AUD |
| Avg. Daily Volume (10-Days) | 39.72K AUD |
| Shares Outstanding | N/A |
| Float | 130.3M |
| Short Ratio | N/A |
| % Held by Insiders | 40.50% |
| % Held by Institutions | 2.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.002697:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -307.97% |
| Gross Margin | 118.50% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -63.83% |
| Return on Equity (ttm) | -117.0029% |
Income Statement
| Revenue (ttm) | 2.72M AUD |
| Revenue Per Share (ttm) | 0.01 AUD |
| Quarterly Revenue Growth (yoy) | 12.09% |
| Gross Profit (ttm) | 2.43M AUD |
| EBITDA | -8244592 AUD |
| Net Income Avi to Common (ttm) | -8252210 AUD |
| Diluted EPS (ttm) | -0.043 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.89M AUD |
| Total Cash Per Share (mrq) | 0.04 AUD |
| Total Debt (mrq) | 128.02K AUD |
| Total Debt/Equity (mrq) | 1.46 AUD |
| Current Ratio (mrq) | 8.262 |
| Book Value Per Share (mrq) | 0.04 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6153406 AUD |
| Levered Free Cash Flow (ttm) | -3201028 AUD |
Profile of Rhythm Biosciences Limited
| Country | Australia |
| State | VIC |
| City | Parkville |
| Address | Bio21 Institute |
| ZIP | 3010 |
| Phone | 61 3 8256 2880 |
| Website | https://www.rhythmbio.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Rhythm Biosciences Limited, a transformative predictive cancer diagnostics technology company in Australia and internationally. The company engages in developing and commercializing medical diagnostics technology. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Q&A For Rhythm Biosciences Limited Stock
What is a current RHY.XA stock price?
Rhythm Biosciences Limited RHY.XA stock price today per share is 0.08 AUD.
How to purchase Rhythm Biosciences Limited stock?
You can buy RHY.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rhythm Biosciences Limited?
The stock symbol or ticker of Rhythm Biosciences Limited is RHY.XA.
How many shares does Rhythm Biosciences Limited have in circulation?
The max supply of Rhythm Biosciences Limited shares is 0.
What is Rhythm Biosciences Limited Price to Earnings Ratio (PE Ratio)?
Rhythm Biosciences Limited PE Ratio is now.
What was Rhythm Biosciences Limited earnings per share over the trailing 12 months (TTM)?
Rhythm Biosciences Limited EPS is -0.043 AUD over the trailing 12 months.